Evidence map›Paper›PMID 16517865›Full record

ArticleJournal of clinical microbiology2006

Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France.

Geraldine Durand, Michèle Bes, Helene Meugnier, Mark C Enright, Françoise Forey, Nadia Liassine, Aline Wenger, Ken Kikuchi, Gerard Lina, François Vandenesch and 1 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Pathogens and global health · 2024
    Review
  3. Article
  4. Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Pathogenicity and Molecular Characterization ofBioMed research international · 2021
    Article
  9. Review
  10. Article
  11. Emergence of novel methicillin-resistantInfection and drug resistance · 2019
    Article
  12. Distribution of the Most PrevalentFrontiers in microbiology · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Antibacterial resistance, genes encoding toxins and genetic background among Staphylococcus aureus isolated from community-acquired skin and soft tissue infections in France: a national prospective survey.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Geraldine DurandCentre National de Référence des Staphylocoques, Faculté Laennec, INSERM E0230, IFR62, 7 Rue Guillaume Paradin, 69372 Lyon cedex 08, France.
Michèle Bes
Helene Meugnier
Mark C Enright
Françoise Forey
Nadia Liassine
Aline Wenger
Ken Kikuchi
Gerard Lina
François Vandenesch
Jerome Etienne
Inserm · FRBioanalytica (Switzerland) · CHTokyo Women's Medical University · JPUniversity Hospital of Lausanne · CHUniversity of Bath · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) clones harboring the toxic shock syndrome toxin 1 (tst) gene have been detected in France and in Switzerland since 2002. During a passive survey conducted between 2002 and 2003, we collected 103 tst-positive S. aureus isolates from 42 towns in France, of which 27 were resistant to methicillin. The tst-positive MRSA belonged to two clones: a major clone comprising 25 isolates of sequence type (ST) 5 and agr group 2 and a minor clone comprising two isolates of ST30 and agr3. The tst-positive MRSA clones were associated with both hospital-acquired (12 cases) and community-acquired (8 cases) infections. The MRSA clones were mainly isolated from children (overall median age, 3 years). They caused a variety of clinical syndromes, including toxic shock syndrome and suppurative infections. Both clones were found to harbor a type IV staphylococcal chromosomal cassette mec (SCCmec) and to have similar antibiotic resistance profiles (usually resistant to oxacillin, kanamycin, and tobramycin and with intermediate resistance to fusidic acid). The origin of these clones is unclear. The tst-positive agr2 MRSA clone has the same sequence type (ST5) of two pandemic nosocomial MRSA clones, namely, the Pediatric clone and the New York/Japan clone. These findings suggest that all these clones are phylogenetically related. The pulsotype of the tst-positive MRSA clones differed from that of methicillin-sensitive S. aureus (MSSA) clones by a single band involving the SCCmec element. These findings suggest that the tst-positive MRSA clones may have emerged from their respective MSSA counterparts.

Indexed as

Genes, BacterialAdolescentAdultAgedAged, 80 and overBacterial ToxinsChildChild, PreschoolCommunity-Acquired InfectionsCross InfectionEnterotoxinsFemaleFranceHumansInfantInfant, NewbornBacterial Toxinsenterotoxin F, StaphylococcalEnterotoxinsSuperantigens

Identifiers

PMID16517865
PMCPMC1393112
OpenAlexW2170847122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.